|
Market Closed -
Japan Exchange
02:30:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 2,278.50 JPY | -0.50% |
|
-6.70% | +4.88% |
| 09-01 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,071B 6.78B 6.05B 5.63B 5.13B 9.65B 653B 9.72B 68.05B 26.48B 333B 25.44B 24.89B | P/E 2027 * |
14.3x | P/E 2028 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 870B 5.5B 4.91B 4.57B 4.16B 7.84B 530B 7.9B 55.27B 21.5B 271B 20.66B 20.22B | EV / Sales 2027 * |
1.89x | EV / Sales 2028 * | 1.83x |
| Free-Float |
82.24% | Yield 2027 * |
3.51% | Yield 2028 * | 3.51% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Deutsche Boerse AG
| ON4 | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Tradegate
| ON4 | Real-time | |
|
Börse Stuttgart
| ON4 | Delayed |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -0.50% | ||
| 1 week | -6.70% | ||
| Current month | -2.90% | ||
| 1 month | -6.94% | ||
| 3 months | -5.81% | ||
| 6 months | -10.03% | ||
| Current year | +4.88% |
| 1 week | 2,268.5 |  | 2,388.5 |
| 1 month | 2,268.5 | | 2,458 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,703 | | 2,674.5 |
| 3 years | 1,474 | | 2,849 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 68 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 68 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | -6.70% | +34.27% | -16.39% | 6.82B | |
| +0.73% | -3.10% | +35.85% | +112.01% | 1,019B | |
| -0.96% | -6.80% | +34.71% | +61.30% | 617B | |
| +0.81% | -1.07% | +14.44% | +78.66% | 464B | |
| -3.03% | -5.98% | +57.43% | +34.94% | 356B | |
| +0.93% | -1.83% | +20.98% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.09% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.56% | +7.91% | 244B | |
| -0.03% | -3.84% | +36.70% | +51.68% | 218B | |
| -0.32% | -5.33% | +26.86% | +92.89% | 179B | |
| Average | -0.39% | -3.81% | +26.38% | +49.80% | 370.4B | |
| Weighted average by Cap. | -0.19% | -3.54% | +28.61% | +68.41% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 460B 2.91B 2.6B 2.42B 2.2B 4.15B 281B 4.18B 29.25B 11.38B 143B 10.93B 10.7B | 449B 2.84B 2.53B 2.36B 2.15B 4.05B 274B 4.08B 28.53B 11.1B 140B 10.67B 10.44B |
| Net income | 74.87B 474M 423M 394M 358M 675M 45.64B 680M 4.76B 1.85B 23.29B 1.78B 1.74B | 64.23B 407M 363M 338M 307M 579M 39.15B 583M 4.08B 1.59B 19.98B 1.53B 1.49B |
| Net Debt | -201B -1.27B -1.14B -1.06B -963M -1.81B -123B -1.83B -12.78B -4.97B -62.56B -4.78B -4.67B | -250B -1.58B -1.41B -1.31B -1.2B -2.25B -152B -2.27B -15.87B -6.17B -77.68B -5.93B -5.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-05 | JP¥2,278.50 | -0.50% | 986,000 |
| 26-10-02 | JP¥2,290.00 | -1.84% | 1,499,300 |
| 26-10-01 | JP¥2,333.00 | -0.58% | 1,609,100 |
| 26-09-30 | JP¥2,346.50 | +0.56% | 1,829,100 |
| 26-09-29 | JP¥2,333.50 | -3.15% | 1,620,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
